MEDTR vs GENTS Comparison
Price, market cap, valuation, profitability and leverage metrics of MEDTR and GENTS side by side.
If You Had Invested TRY 10,000
Metric Comparison
| Metric | MEDTR | GENTS | Sector median |
|---|---|---|---|
| Last price (TL) | 18.30 | 4.11 | 18.72 |
| Daily change | −5.67% | −5.73% | −5.85% |
| Market cap | TRY 2.2B | TRY 3.1B | TRY 4.3B |
| P/E | 66.43 | 7.16 | 17.35 |
| P/B | 0.69 | 0.78 | 1.09 |
| Dividend yield | 0.44% | 2.01% | 0.90% |
| Return on equity | 1.14% | 12.48% | 1.78% |
| Free float | 20.21% | 72.08% | 37.21% |
Popular Comparisons
Related Pages
About the MEDTR vs GENTS Comparison
Price, market cap, valuation multiples, profitability and leverage of MEDTR (Meditera Tibbi Malzeme) and GENTS (Gentas) side by side as of Sep 28, 2026, 13:50. Of the 15 metrics compared, MEDTR leads in 6 and GENTS leads in 9.
Highlights: Daily change: MEDTR leads (−5.67% vs −5.73%). Market cap: GENTS leads (TRY 3.1B vs TRY 2.2B). P/E: GENTS leads (7.16 vs 66.43). P/B: MEDTR leads (0.69 vs 0.78). EV/EBITDA: GENTS leads (4.12 vs 7.60). EV/Sales: GENTS leads (1.17 vs 1.36). Dividend yield: GENTS leads (2.01% vs 0.44%). Gross margin: MEDTR leads (33.71% vs 21.69%).
Frequently Asked Questions
Is MEDTR or GENTS cheaper?
By P/E, GENTS is cheaper (66.43 vs 7.16); by P/B, MEDTR trades at the lower multiple (0.69 vs 0.78).
Which is more profitable, MEDTR or GENTS?
Annual net margin is 1.35% for MEDTR and 9.17% for GENTS; return on equity is 1.14% for MEDTR and 12.48% for GENTS.
Which is more leveraged, MEDTR or GENTS?
The leverage ratio is 15.79 for MEDTR and 33.34 for GENTS; net debt/EBITDA is — for MEDTR and −0.20 for GENTS. Lower values mean less leverage.
Where does the comparison data come from?
Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.